Cointime

Aegera Therapeutics

company

About

Aegera Therapeutics, part of Pharmascience Inc., is focused on developing targeted therapeutics to address major unmet medical needs.

  • 11 - 50

Highlights

Total Funding Amount
$17M
Funding Rounds
1
Investors
2

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$17M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 1997
Number Of Employee
11 - 50
Operating Status
Close

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain.

Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$17M
Aegera Therapeutics has raised a total of $17M in funding over 2 rounds. Their latest funding was raised on Mar 4, 2002 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 4, 2002 Series Unknown $17M 2 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
Aegera Therapeutics is funded by 2 investors. Canadian Medical Discoveries Fund and Innovatech Grand Montreal are the most recent investors.
Investor Name Lead Investor Funding Round
Canadian Medical Discoveries Fund — Series Unknown
Innovatech Grand Montreal — Series Unknown
Cointime
เนื้อหา
บริษัท